Stay updated on Nivolumab Dose Optimization Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Dose Optimization Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Dose Optimization Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The error page footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T01:51:44.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    An error page (403 Forbidden) is displayed for the study URL, replacing expected content with a 403 screen that includes a Home link and a revision notice, signaling restricted access rather than updated study information.
    Difference
    18%
    Check dated 2026-09-20T00:57:58.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The study page now lists related topics: Lung cancer and MedlinePlus Genetics. These entries connect the trial to broader cancer topics and a genetics information resource.
    Difference
    0.1%
    Check dated 2026-09-12T23:36:15.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.6.6. The previous revision tag (v3.6.5) and several related topic links (Lung cancer, related topics:, MedlinePlus Genetics) have been removed.
    Difference
    0.1%
    Check dated 2026-08-29T19:52:14.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now includes a new topic tag 'Lung cancer' and a related topics entry 'MedlinePlus Genetics', expanding the navigation to associated health information.
    Difference
    0.1%
    Check dated 2026-08-22T21:43:49.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Added a new page revision label v3.6.5 to the study record. Removed the core condition label 'Lung cancer', the 'related topics' header, the 'MedlinePlus Genetics' link, and the older revision label v3.6.4, altering the page's content labeling and navigation.
    Difference
    0.1%
    Check dated 2026-08-08T16:35:28.000Z thumbnail image

Stay in the know with updates to Nivolumab Dose Optimization Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Dose Optimization Clinical Trial page.